Evidence map›Paper›PMID 32614656›Full record

ArticleHuman vaccines & immunotherapeutics2020

Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups.

Lise Boey, Eline Bosmans, Liane Braz Ferreira, Nathalie Heyvaert, Melissa Nelen, Lisa Smans, Hanne Tuerlinckx, Mathieu Roelants, Kathleen Claes, Inge Derdelinckx and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Non-invasiveEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Lise BoeyLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0001-9623-4482
Eline BosmansLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Liane Braz FerreiraLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Nathalie HeyvaertLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Melissa NelenLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Lisa SmansLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Hanne TuerlinckxLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Mathieu RoelantsEnvironment and Health, Department of Public Health and Primary Care, KU Leuven , Leuven, Belgium.ORCID 0000-0002-3749-0475
Kathleen ClaesDepartment of Nephrology and Renal Transplantation, University Hospitals Leuven , Leuven, Belgium.
Inge DerdelinckxDepartment of General Internal Medicine, University Hospitals of Leuven , Leuven, Belgium.
Wim JanssensDepartment of Respiratory Diseases, University Hospitals of Leuven , Leuven, Belgium.
Chantal MathieuDepartment of Endocrinology, University Hospitals of Leuven , Leuven, Belgium.
Johan Van CleemputDepartment of Cardiology, University Hospitals of Leuven , Leuven, Belgium.
Robin VosDepartment of Respiratory Diseases - Lung Transplantation Unit, University Hospitals of Leuven , Leuven, Belgium.
Corinne VandermeulenLeuven University Vaccinology Center , Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.ORCID 0000-0002-1954-7554
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon exposure to vaccine-preventable diseases, certain individuals are at increased risk for complications due to preexisting diseases, age or immunosuppressive treatment. Vaccination against influenza, pneumococcal disease and hepatitis B (for some groups) is advised in addition to standard vaccination against diphtheria, tetanus and pertussis. We estimated the vaccination coverage and determinants of recommended vaccinations in patients with diabetes mellitus type 1 (n = 173) and type 2 (n = 177), chronic kidney disease (CKD) (n = 138), heart failure (n = 200), chronic obstructive pulmonary disease (COPD) (n = 187), HIV (n = 201) or solid organ transplantation (SOT) (n = 201) in a monocentric study. Vaccination data were retrieved from documents provided by patients and general practitioners, and from the Flemish vaccination register. Less than 10% had received all recommended vaccines. Overall, 29% of subjects were vaccinated against diphtheria-tetanus, 10% against pertussis, 44% against influenza, 32% against pneumococcal disease and 24% of HIV patients and 31% of CKD patients against hepatitis B. Age was positively associated with vaccination against influenza (OR:2.0,

Indexed as

HIV InfectionsInfluenza VaccinesHumansPneumococcal VaccinesTetanus ToxoidVaccinationVaccination CoverageInfluenza VaccinesPneumococcal VaccinesTetanus Toxoidat-risk groupsdeterminantsRecommended vaccinesvaccination coverage

Identifiers

PMID32614656
PMCPMC7553698
OpenAlexW3038661701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.